Nancy June Hutson Ph.D.
|Age||Total Calculated Compensation||This person is connected to 56 board members in 7 different organizations across 7 different industries.|
See Board Relationships
Dr. Nancy June Hutson, Ph.D., serves as the Chair of the Groton New London Laboratories Leadership Team and the Exploratory Development Strategy Team. Dr. Hutson has been an Independent Director of Endo International plc since February 28, 2014. She has been a Director of BioCryst Pharmaceuticals, Inc. since January 20, 2012 and Inspire Pharmaceuticals, Inc. since October 27, 2006. She has been a Director of Endo Pharmaceuticals Solutions Inc. since March 30, 2009. She ...
65 Hayden AvenuePhone: 781-860-8660
Lexington, Massachusetts 02421
Board Members Memberships*
Illinois Wesleyan University
University of Oxford
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Sijmen de Vries M.D., MBA||Chairman of Management Board and Chief Executive Officer|
Pharming Group N.V.
|Andrew Philip Witty||Chief Executive Officer and Executive Director|
|Flemming Ornskov M.D., MBA, MPH||Chief Executive Officer, Managing Director and Director|
|Joji Nakayama||Chief Executive Officer, President and Representative Director|
Daiichi Sankyo Company, Limited
|¥140.0M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.